UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: SimvastatinBluefish-40mg-Tablet-SE-BS-MPD

Generated Narrative: MedicinalProductDefinition SimvastatinBluefish-40mg-Tablet-SE-BS-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-100002566-00026679, http://ema.europa.eu/fhir/eurdId/2709

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Film-coated tablet

indication:

Hypercholesterolaemia Treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (such as exercise, weight reduction) is inadequate. Treatment of homozygous familial hypercholesterolaemia (HoFH) as an adjunct to diet and other lipid-lowering treatments (e.g. LDL-apheresis) or if such treatments are not appropriate. Cardiovascular prevention Reduction of cardiovascular mortality and morbidity in patients with manifest atherosclerotic cardiovascular disease or diabetes mellitus, with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors and other cardioprotective therapy (see section 5.1).

legalStatusOfSupply: Medicinal product subject to medical prescription

classification: simvastatin

name

productName: Simvastatin Bluefish 40 mg filmdragerad tablett

part

part: SimvastatinBluefish

type: Scientific name part

part

part: 40 mg

type: Strength part

part

part: Filmdragerad tablett

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish